NanoViricides Inc.

AMEX: NNVC · Real-Time Price · USD
1.49
0.02 (1.71%)
At close: Aug 15, 2025, 3:59 PM
1.49
0.00%
After-hours: Aug 15, 2025, 07:35 PM EDT

NanoViricides Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 190.6K 189.96K 189.33K 189.12K 188.88K 188.32K 186.92K 183.4K 187.96K 181.56K 177.39K 176.42K 176.16K 176.14K n/a n/a
Gross Profit
n/a n/a n/a -190.6K -189.96K -189.33K -189.12K -188.88K -188.32K -186.92K -183.4K -187.96K -181.56K -177.39K -176.42K -176.16K -176.14K n/a n/a
Operating Income
-2.25M -2.06M -3.17M -2.39M -1.91M -2.18M -2.03M -3.68M -1.81M -1.83M -1.62M -1.79M -1.79M -1.92M -2.61M -2.07M -2.11M -2.29M -2.27M
Interest Income
32.37K 31.71K 41.02K 35.37K 53.93K 83.13K 99.34K 106.38K 107.94K 88.95K 52.56K n/a n/a 2.07K 188.00 3.08K 2.02K 1.19K 3.06K
Pretax Income
-2.22M -2.03M -3.13M -2.36M -1.85M -2.11M -1.97M -3.57M -1.7M -1.75M -1.57M -1.78M -1.79M -1.92M -2.61M -2.07M -2.11M -2.33M -2.31M
Net Income
-2.22M -2.03M -3.13M -2.36M -1.85M -2.11M -1.97M -3.57M -1.59M -1.66M -1.52M -1.78M -1.8M -1.92M -2.61M -2.07M -2.11M -2.33M -2.31M
Selling & General & Admin
966.9K 902.7K 1.23M 1.21M 503.79K 421.55K 564.93K 763.42K 614.65K 663.28K 509.7K 621.22K 532.8K 659.27K 515.45K 490.17K 643.36K 798.72K 697.31K
Research & Development
1.28M 1.16M 1.93M 1.18M 1.21M 1.57M 1.47M 2.91M 1.2M 1.17M 1.11M 1.17M 1.26M 1.26M 2.1M 1.58M 1.46M 1.49M 1.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
2.25M 2.06M 3.17M 2.39M 1.72M 2M 2.03M 3.68M 1.81M 1.83M 1.62M 1.79M 1.79M 1.92M 2.61M 2.07M 2.11M 2.29M 2.27M
Interest Expense
n/a 149.00 n/a n/a n/a 13.31K 36.49K n/a n/a 94.00 844.00 n/a 4.79K 2.63K 891.00 1.69K 2.52K 37.29K 43.91K
Selling & Marketing Expenses
n/a n/a n/a n/a -189.96K -189.33K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 2.06M 3.17M 2.39M 1.91M 2.18M 2.03M 3.68M 1.81M 1.83M 1.62M 1.79M 1.79M 1.92M 2.61M 2.07M 2.11M 2.29M 2.27M
Income Tax Expense
n/a n/a n/a n/a 4.00 n/a n/a n/a -107.94K -88.86K -51.72K 11.86K 4.79K 2.63K 188.00 3.08K 2.02K n/a 3.06K
Shares Outstanding (Basic)
16.03M 14.57M 13.72M 11.87M 11.78M 11.75M 11.72M 11.7M 11.64M 11.61M 11.59M 11.56M 11.54M 11.53M 11.52M 10.95M 10.95M 10.67M 10.49M
Shares Outstanding (Diluted)
16.03M 14.57M 13.72M 11.87M 11.78M 11.75M 11.72M 11.7M 11.64M 11.61M 11.59M 11.56M 11.54M 11.53M 11.52M 10.95M 10.95M 10.67M 10.49M
EPS (Basic)
-0.14 -0.14 -0.23 -0.2 -0.16 -0.18 -0.17 -0.31 -0.14 -0.14 -0.13 -0.15 -0.16 -0.17 -0.23 -0.19 -0.19 -0.22 -0.22
EPS (Diluted)
-0.14 -0.14 -0.23 -0.2 -0.16 -0.18 -0.17 -0.31 -0.14 -0.14 -0.13 -0.15 -0.16 -0.17 -0.23 -0.19 -0.19 -0.22 -0.22
EBITDA
-2.25M -1.83M -2.97M -2.17M -1.66M -1.91M -1.74M -3.38M -1.51M -1.56M -1.39M -1.59M -1.61M -1.74M -2.44M -1.9M -1.93M -2.12M -2.09M
EBIT
n/a -2.03M -3.13M -2.36M -1.85M -2.1M -1.93M -3.57M -1.7M -1.75M -1.57M -1.78M -1.79M -1.92M -2.61M -2.07M -2.11M -2.29M -2.27M
Depreciation & Amortization
n/a 195.88K 195.61K 190.6K 189.96K 189.33K 189.12K 188.88K 188.32K 186.92K 183.4K 187.96K 181.56K 177.39K 176.42K 176.16K 176.14K 175K 177.23K